Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor Cell (CTC) Quantification During Transurethral Resection (TURBT) and Plasma Kinetic Vaporisation (PKVBT) of Transitional Cell Carcinoma in Purging Fluid and Blood: a Randomized Controlled Trial

NCT04811846 is registered in ClinicalTrials.gov with University Teaching Hospital Hall in Tirol as lead sponsor.

NCT NCT04811846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04811846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor Cell (CTC) Quantification During Transurethral Resection (TURBT) and Plasma Kinetic Vaporisation (PKVBT) of Transitional Cell Carcinoma in Purging Fluid and Blood: a Randomized Controlled Trial
Lead sponsor
University Teaching Hospital Hall in Tirol
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 14, 2021
Completion date
October 31, 2025
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cell, neoplasms, transitional cell carcinoma, urinary bladder neoplasm, urogenital neoplasms